Literature DB >> 25931365

Dimethylarginines as risk markers of atherosclerosis and chronic kidney disease in children with nephrotic syndrome.

Lidia Hyla-Klekot1, Piotr Bryniarski2, Barbara Pulcer1, Katarzyna Ziora3, Andrzej Paradysz2.   

Abstract

BACKGROUND: Nephrotic syndrome in children is commonly associated with dyslipidemia, which is considered a risk factor for endothelial dysfunction and atherosclerosis. Recently new markers of endothelial dysfunction, such as asymmetric dimethylarginine (ADMA), have gained importance. Another L-arginine derivative--symmetric dimethylarginine (SDMA)--may reflect the glomerular filtration rate (GFR).
OBJECTIVES: The main aim of this study was to assess ADMA as a marker of atherosclerosis. Secondly, SDMA was examined for GFR assessment.
MATERIAL AND METHODS: The study involved 32 children with nephrotic syndrome. Several parameters were examined in the remission and relapse phases of nephrotic syndrome, including ADMA, SDMA, cholesterol, triglycerides and GFR.
RESULTS: In the relapse phase there was a negative correlation between ADMA and lipids (cholesterol and triglycerides). In both phases SDMA was negatively correlated with GFR.
CONCLUSIONS: The role of ADMA as a marker for endothelial dysfunction is not significant. SDMA may be utilized to monitor GFR in children with nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25931365     DOI: 10.17219/acem/40465

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  3 in total

1.  Real-time functional characterization of cationic amino acid transporters using a new FRET sensor.

Authors:  Liviu Vanoaica; Alok Behera; Simone M R Camargo; Ian C Forster; François Verrey
Journal:  Pflugers Arch       Date:  2015-11-11       Impact factor: 3.657

2.  Arginine dimethylation products in pediatric patients with chronic kidney disease.

Authors:  Akram E El-Sadek; Eman G Behery; Ahmed A Azab; Naglaa M Kamal; Mostafa A Salama; Waleed E Abdulghany; Enas A A Abdallah
Journal:  Ann Med Surg (Lond)       Date:  2016-06-02

3.  Asymmetric dimethylarginine is not a marker of arterial damage in children with glomerular kidney diseases.

Authors:  Piotr Skrzypczyk; Joanna Przychodzień; Małgorzata Mizerska-Wasiak; Elżbieta Kuźma-Mroczkowska; Anna Stelmaszczyk-Emmel; Elżbieta GóRSKA; Małgorzata Pańczyk-Tomaszewska
Journal:  Cent Eur J Immunol       Date:  2020-01-20       Impact factor: 2.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.